Rene Sindlev - 01 Aug 2023 Form 4 Insider Report for RENOVARO BIOSCIENCES INC. (RENB)

Role
Director, 10%+ Owner
Signature
/s/ Rene Sindlev
Issuer symbol
RENB
Transactions as of
01 Aug 2023
Transactions value $
$499,998
Form type
4
Date filed
12 Sep 2023, 06:08
Previous filing
01 Aug 2023
Next filing
15 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RENB Series A Convertible Preferred Stock Award $500K +70.1K $7.13 70.1K 01 Aug 2023 Common Stock 701K $0.00 By RS Bio ApS F1, F2
transaction RENB Warrant (Right to Buy) Award $0 +351K $0.00 351K 01 Aug 2023 Common Stock 351K $0.65 By RS Bio ApS F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Series A Convertible Preferred Stock ("Preferred Stock") is convertible into Common Stock on a one-for-ten basis
F2 The Preferred Stock is perpetual and has no expiration date.
F3 Granted to the Reporting Person as warrant coverage in connection with the Preferred Stock reported above.